Healthy Volunteer Clinical Trial
Official title:
High-Density Direct Current Brain Polarization
Verified date | February 9, 2012 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background:
- Direct current (DC) brain polarization is a technique in which very weak electricity is
applied to the head. Doctors have used DC polarization for many years on patients and
healthy people with no known serious side effects. Earlier, researchers found that DC
polarization can temporarily improve the ability of healthy people to think of certain
words.
- A disadvantage of existing methods of DC polarization is that they use large electrodes
and the current spreads over a large area of the brain. This makes it difficult to
target particular brain areas. High-density DC polarization uses several small
electrodes to focus the current in a small area of the brain. This study will test
high-density DC polarization for the first time in humans.
Objectives:
- To see how well high-density direct current polarization works in the brain.
- To test a new method of performing direct current brain polarization.
Eligibility:
- Healthy, right-handed adults, ages 18 and older, who have no history of neurological or
psychiatric illnesses.
Design:
- After an initial screening visit with clinical examination, participants may be assigned
to one or both experiments of the study.
- Experiment 1: Participants will have electrodes placed on the left side of their heads,
and will be asked to say aloud as many words as they can think of that begin with
certain letters. After the high-density DC polarization current is turned on and run for
10 minutes, participants will say words beginning with a different set of letters and
perform reaction time and thinking speed tests. Some participants will receive real
polarization and others will not, although all participants will be told that they are
receiving the polarization.
- Experiment 2: Participants will have DC brain polarization performed with transcranial
magnetic stimulation (TMS), which uses magnetic pulses to activate nerve cells in the
brain. We will use TMS to help us understand how far the effect of DC polarization
spreads in the brain. After attaching electrodes to a point on the scalp above the ear,
researchers will give about 50 TMS pulses to five different places near this area. These
pulses will produce some painless muscle twitches in the hand or arm. The TMS pulses
will be followed by the DC brain polarization, and then by another set of TMS pulses to
see if there are any differences in muscle response.
Status | Completed |
Enrollment | 30 |
Est. completion date | April 5, 2011 |
Est. primary completion date | April 5, 2011 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
- INCLUSION CRITERIA: Healthy volunteers over age 18 EXCLUSION CRITERIA: Any history of central nervous system illness or behavioral disorder Broken skin or other lesions in the area of the electrodes Uncontrolled medical problems, such as diabetes mellitus, hypertension, pulmonary or airway disease, heart failure, coronary artery disease, or any other condition that poses a risk for the subject during participation or potentially worsen the outcome of a burn Presence of metal in the cranial cavity Holes in the skull made by trauma or surgery Pacemakers, medication pumps, and other implanted electronic hardware Pregnancy (female volunteers who have the potential to become pregnant will have urine pregnancy test performed within 24 hours of participation) Left handers will be excluded from Experiment 1 |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Bikson M, Radman T, Datta A. Rational modulation of neuronal processing with applied electric fields. Conf Proc IEEE Eng Med Biol Soc. 2006;1:1616-9. Review. — View Citation
BINDMAN LJ, LIPPOLD OC, REDFEARN JW. Long-lasting changes in the level of the electrical activity of the cerebral cortex produced bypolarizing currents. Nature. 1962 Nov 10;196:584-5. — View Citation
CREUTZFELDT OD, FROMM GH, KAPP H. Influence of transcortical d-c currents on cortical neuronal activity. Exp Neurol. 1962 Jun;5:436-52. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Verbal fluency; focality of effect on MEP (exploratory) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06326723 -
Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT00001367 -
Diagnosis and History Study of Patients With Different Neurological Conditions
|
||
Completed |
NCT02699710 -
Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects
|
Phase 1 | |
Completed |
NCT02231892 -
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
|
N/A | |
Not yet recruiting |
NCT06441916 -
Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT03771586 -
A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06337422 -
Bioequivalence Study of Generic Celecoxib 200 mg Capsules
|
Phase 1 | |
Completed |
NCT03302182 -
Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT05049343 -
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT01629108 -
Normal Values in Hearing and Balance Testing
|
||
Completed |
NCT02947854 -
Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant
|
Phase 1 | |
Completed |
NCT02534870 -
Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT02224053 -
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01697436 -
A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets
|
Phase 1 | |
Completed |
NCT01711762 -
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT01684891 -
A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT01676584 -
A Study of Single Dose RO6811135 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01591850 -
A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01414881 -
Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01461967 -
A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers
|
Phase 1 |